Eurogentec

CDMO focussed on oligonucletoide, peptide and antibody development and manufacturing

placeSeraing, Wallonia, Belgium calendar_todayFounded 1985 groups426 employees language eurogentec.com

Innovation

1 patent family (1 granted) — focus: Physics & computing; filing pace dormant. Cited 13 times.

YearFilings
20131
20161

Social engagement

Social engagement: 16.1K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

2 investors on record.

Investor typeCountShare
Venture capital150%
Other / undisclosed150%

Recent activity

30 Jun 2026
Product launch
AccessTM portfolio includes IP free dye and quencher couples covering all qPCR channels
30 Jun 2026
Event
Antibody Industrial Symposium
19 Jun 2026
Event
BIO2026
Coming soon